Tymazoline
![Ehealth DSI [Ehdsi V2.2.1] European Commission](http://data.docslib.org/img/264x/2d8312ad5214a07d6e0a1e4da92b67e4.webp)
Top View
- Method and Composition for Increased Skin Concentration of Active Agents by Iontophoresis
- Solutions Your Api Intermediates
- Australian Statistics on Medicines 2009
- WO 2010/141834 Al
- Pharmaceutical Composition for Ophthalmic Use Comprising A
- (12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
- Summary of Product Characteristics 1. Name Of
- Supplementary Information Molecules Repartition Into the Various Groups
- Table of Drugs and Chemicals (FY12)
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- Medicines Regulations 1984 (SR 1984/143)
- Required Advisory Statements for Medicine Labels
- (19) United States (12) Patent Application Publication (10) Pub
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- International Classification of Procedures in Medicine
- Medicines Amendment Regulations (No 2) 2015
- Xylometazoline Hydrochloride)
- Required Advisory Statements for Medicine Labels